Physician profile
Patrick J Perkins
NPI 1437159308
$8,409.45
in general payments reported to CMS, 2019-2025
12 companies · $7,051 in 2025
The $7,051 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $84.69 · 2021: $77.06 · 2022: $726 · 2024: $68.88 · 2025: $7,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $119.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,053.14 | 2024-2025 | |
| Olympus Corporation of The Americas | $690.01 | 2022 | |
| Glaxosmithkline, LLC. | $165.21 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $150.12 | 2019-2024 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.67 | 2019-2024 | Ofev |
| Genentech USA, INC. | $84.07 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $36.00 | 2019-2020 | |
| Genzyme Corporation | $32.12 | 2024-2025 | |
| Veran Medical Technologies, INC. | $31.31 | 2021 | |
| Medtronic, INC. | $18.44 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.20 | 2019 | |
| Mylan Specialty L.P. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.